* SCI and SCIE
Oh SY, Jeong CY, Hong SC, Kim TH, Ha CY, Kim HJ, Lee GW, Hwang IG, Jang JS, Kwon HC, Kang JH. Phase II study of second line gemcitabine single chemotherapy for biliary tract cancer patients with 5-fluorouracil refractoriness. Invest New Drugs 2011 Oct;29(5):1066-72
Hwang IG, Jang JS, Do JH, Kang JH, Lee GW, Oh SY, Kwon HC, Jun HJ, Lim HY, Lee S, Chi KC, Lee SJ. Different relation between ERCC1 overexpression and treatment outcomes of two platinum agents in advanced biliary tract adenocarcinoma patients. Cancer Chemother Pharmacol. 2011 Oct; 68(4):935-44. Epub 2011 Feb 5.
Rakib MA, Kim YS, Jang WJ, Jang JS, Kang SJ, Ha YL. Preventive effect of t,t-conjugated linoleic acid on 12-O-tetradecanoylphorbol-13-acetate-induced inhibition of gap junctional intercellular communication in human mammary epithelial MCF-10A cells. J Agric Food Chem. 2011 Apr 27;59(8):4164-70. Epub 2011 Mar 10.
국내자료를 근거로 한 호중구감소성 발열 환자의 경험적 치료지침. 이동건, 김성한, 김수영, 민창기, 박완범, 박연준, 송영구, 장정순, 장준호, 진종률, 최정현. Infect Chemother 2011:43(4):285-321 pISSN 2093-2340
Korean J Intern Med. 2011 Jun;26(2):220-52. Epub 2011 Jun 1.
Evidence-based guidelines for empirical therapy of neutropenic fever in Korea.
Lee DG, Kim SH, Kim SY, Kim CJ, Park WB, Song YG, Choi JH.
Oh SY, Jeong CY, Hong SC, Kim TH, Ha CY, Kim HJ, Lee GW, Hwang IG, Jang JS, Kwon HC, Kang JH. Phase II study of second line gemcitabine single chemotherapy for biliary tract cancer patients with 5-fluorouracil refractoriness. Invest New Drugs. 2011 Oct;29(5):1066-72. Epub 2010 Apr 1. PMID: 20358256
Outcomes of Third-line Docetaxel-Based Chemotherapy in Advanced Gastric Cancer Who Failed Previous Oxaliplatin-Based and Irinotecan-Based Chemotherapies.
Lee MJ, Hwang IG, Jang JS, Choi JH, Park B, Chang MH, Kim ST, Park SH, Kang MH, Kang JH. Cancer research and treatment. 2012;44(4):235-241.
Prognostic factors in primary diffuse large B-cell lymphoma of adrenal gland treated with rituximab-CHOP chemotherapy from the Consortium for Improving Survival of Lymphoma (CISL). Kim YR, Kim JS, Min YH, Hyunyoon D, Shin HJ, Mun YC, Park Y, Do YR, Jeong SH, Park JS, Oh SY, Lee S, Park EK, Jang JS, Lee WS, Lee HW, Eom H, Ahn JS, Jeong JH, Baek SK, Kim SJ, Kim WS, Suh C. Prognostic factors in primary diffuse large B-cell lymphoma of adrenal gland treated with rituximab-CHOP chemotherapy from the Consortium for Improving Survival of Lymphoma (CISL). J Hematol Oncol. 2012 Aug 13;5:49. PMID: 22889180 [PubMed - in process]
A prospective multicentre phase II study of cisplatin and weekly docetaxel as first-line treatment for recurrent or metastatic nasopharyngeal cancer (KCSG HN07-01). Ji JH; Korean Cancer Study Group (KCSG), Yun T, Kim SB, Kang JH, Park JC, Cho IS, Sohn CH, Heo DS, Jang JS, Shin SW, Hwang DW, Sun JM, Park K, Ahn MJ. Eur J Cancer. 2012 Nov;48(17):3198-204. doi: 10.1016/j.ejca.2012.06.009. Epub 2012 Jul 13.
PMID: 22795584 [PubMed - in process]
A phase II trial of Erlotinib in combination with gemcitabine and cisplatin in advanced pancreatic cancer.
Hwang IG, Jang JS, Oh SY, Lee S, Kwon HC, Lee GW, Go S, Kang MH, Cha YJ, Kang JH. Invest New Drugs. 2012 Feb 3 ;30:2371-2376. [Epub ahead of print] PMID: 22302349
Gemcitabine and oxaliplatin with or without erlotinib in advanced biliary-tract cancer: a multicentre, open-label, randomised, phase 3 study.
Lee J, Park SH, Chang HM, Kim JS, Choi HJ, Lee MA, Jang JS, Jeung HC, Kang JH, Lee HW, Shin DB, Kang HJ, Sun JM, Park JO, Park YS, Kang WK, Lim HY.
Lancet Oncol. 2012 Feb;13(2):181-8. Epub 2011 Dec 20. PMID: 22192731
Phase II study of salvage mFOLFOX (5-fluorouracil, leucovorin, oxaliplatin) in patients with unresectable biliary tract cancer who had failed gemcitabine EUROPEAN JOURNAL OF CANCER ELSEVIER SCI LTD, THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND, OXON, OX5 1GB 2013.09.01
Predictive value of geriatric assessment for elderly patients, treated with first-line chemotherapy EUROPEAN JOURNAL OF CANCER ELSEVIER SCI LTD, THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND, OXON, OX5 1GB 2013.09.01
A prospective multicenter, single blinded, randomized phase III trial to compare the efficacy of ramosetron, aprepitant and dexamethasone with ondansetron, aprepitant, and dexamethasone for preventing chemotherapy-induced nausea and vomiting: KCSG PC10-21. JOURNAL OF CLINICAL ONCOLOGY AMER SOC CLINICAL ONCOLOGY, 2318 MILL ROAD, STE 800, ALEXANDRIA, USA, VA, 22314 2013.05.20
Biweekly docetaxel/cisplatin vs gemcitabine/cisplatin as first-line therapy for advanced non small cell lung cancer patients who are elderly or poor performance status: Randomized multicenter phase II trial EUROPEAN JOURNAL OF CANCER ELSEVIER SCI LTD, THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND, OXON, OX5 1GB 2013.09.01